{{Rsnum
|rsid=4942242
|Gene=ENOX1
|Chromosome=13
|position=43642928
|Orientation=plus
|GMAF=0.4844
|Gene_s=ENOX1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 46.9 | 22.1
| HCB | 37.2 | 47.4 | 15.3
| JPT | 26.5 | 46.9 | 26.5
| YRI | 22.4 | 47.6 | 29.9
| ASW | 22.8 | 49.1 | 28.1
| CHB | 37.2 | 47.4 | 15.3
| CHD | 29.4 | 49.5 | 21.1
| GIH | 35.6 | 41.6 | 22.8
| LWK | 20.9 | 45.5 | 33.6
| MEX | 24.1 | 39.7 | 36.2
| MKK | 28.8 | 51.3 | 19.9
| TSI | 28.4 | 50.0 | 21.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=2E-7
|OR=0.1300
|ORtxt=None
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}